Red Flags Detected

  • Disclosure Controls And Procedures Were Not Effective (new) — Company disclosed ineffective disclosure controls as of March 31, 2026, citing inadvertent omission of management's report on internal control from prior year's 10-K.
  • Going Concern (worsened) — Going concern disclosure now explicitly cites mandatory liquidation risk and liquidity issues, whereas prior period cited only insufficient funds risk.
NASDAQ: TDACW Translational Development Acquisition Corp. 10-Q

TDACU discloses ineffective controls, working capital deficit, and heightened liquidation risk

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~1 min read

Key Changes

  • high

    Management concluded disclosure controls were NOT effective as of March 31, 2026, citing inadvertent omission of internal control report from prior year's 10-K—a reversal from prior quarter's 'effective' conclusion.

    Controls & Procedures verify on EDGAR →
  • high

    Working capital flipped from +$93K surplus to -$786K deficit as cash fell from $207K to $25K, forcing reliance on a new $2M sponsor promissory note (already $500K drawn).

    MD&A: Liquidity verify on EDGAR →
  • high

    Going concern language now explicitly ties substantial doubt to mandatory liquidation risk if no business combination closes by June 2026 deadline, up from prior period's generic insufficient-funds warning.

    MD&A: Going Concern verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SJM 10-K) is open in full — no account needed.

Partner

Trade TDACW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.